To include your compound in the COVID-19 Resource Center, submit it here.

Pharmascience to pay $17.4M to recapitalize Bellus

Generics company Pharmascience Inc. (Montreal, Quebec) will pay C$17.3 million ($17.4 million) to recapitalize Bellus Health Inc. (TSX:BLU) into a new

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE